The interdisciplinary initiative will bring together biomedical, social science and other data-driven expertise from the university to identify what factors influence an individual’s health and how these insights can inform personalized prevention, diagnosis and treatment recommendations.
The initiative’s first project centers on opioid prescribing trends. Through analyzing behavioral, genomic, environmental and social information, the researchers will attempt to detect risk factors that increase the likelihood of opioid misuse.
The precision health effort will also tap social work researchers to investigate the social implications of precision health approaches and law school faculty to examine potential privacy concerns. In total, more than 19 of the university’s schools and programs will be involved in the initiative.
“The University of Michigan is perfectly positioned to be a global leader in precision health because of our spectacular breadth and collaborative ethos,” Mr. Schlissel said.
More articles on data analytics & precision medicine:
FDA, George Washington University publish framework to streamline genomic data analysis
Indiana University enters into nonprofit, for-profit partnership for precision medicine research
56% of hospital CIOs, CMIOs struggle with data governance, survey finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.